Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
WittGen Biotechnologies
WittGen Bio leverages AI to analyze single-cell data, aiming to uncover new cancer therapeutic opportunities. Their platform, LEIBER-X, is designed to identify novel targets and biomarkers, monitor…
WittGen Biotechnologies
WittGen Bio leverages AI to analyze single-cell data, aiming to uncover new cancer therapeutic opportunities. Their platform, LEIBER-X, is designed to identify novel targets and biomarkers, monitor…
TL;DR
Founded: 2023
Headquarters: Berkeley, California
Core product: LEIBER-X / Virtual Cell single-cell profiling platform
Focus: AI-driven single-cell analysis for oncology target & biomarker discovery
Seed investor(s): Plug and Play; additional backers reported: Primer, Hatcher+
Company Overview
Problem Domain
Translational oncology: target discovery, biomarker identification, mechanism-of-action monitoring, and patient stratification.
Founded
2023
Industry
Biotechnology
Tech Stack
Funding Track Record
Seed round announced June 6, 2023.
Investor Signal
“Plug and Play; additional backers reported: Primer, Hatcher+”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
80,000+
Open Roles
4,300+
New This Week